Key Takeaways
- More than 60% of business buyers in Forrester's survey of nearly 18,000 buyers purchased some form of trial, but only just over a third planned to convert to a fully paid version.
- Trial use climbs to 78% for purchases of $10 million or more, according to Forrester's State of Business Buying, 2026.
- Evaluation is now the longest stage of the software buying journey, surpassing research for the first time, in G2's survey of 1,038 B2B software decision-makers.
- Buyers in TrustRadius's 2026 study averaged shortlists of just 2.7 products, and 67% bought their first choice.
For most of the last decade, the hardest part of a B2B deal was getting onto the shortlist. That has flipped. AI assistants and peer reviews now put buyers on a short list of familiar names within days, and the work that used to happen in discovery calls has moved into trials, pilots, and proofs of concept that the buyer runs largely on their own terms. The result is a stage most revenue teams still treat as a technical formality, but which is now where the majority of their pipeline is quietly being decided.
Everyone Is Trialing, Few Are Committing
Forrester's State of Business Buying, 2026, built on its Buyers' Journey Survey of nearly 18,000 business buyers, found that more than 60% of buyers reported purchasing some form of trial, from paid sandboxes to bespoke proofs of concept. Yet only just over a third of buyers said they planned to convert to a fully paid version. Forrester's framing is blunt: risk-averse buyers want demonstrated value, not vendor claims.
The stakes rise with deal size. In Forrester's announcement of the findings, trial use climbs to 78% for purchases of $10 million or more. The typical decision now involves 13 internal stakeholders and nine external influencers, and procurement acts as a decision-maker in 53% of buying cycles, engaging from the start. Barbara Winters, Vice President and Principal Analyst at Forrester, said buyers "are under immense pressure to justify investments and minimize risk."
Put those numbers together and a trial is no longer a late-stage courtesy. It is the evaluation. A buying group of more than a dozen people, with procurement in the room, is using a few weeks of hands-on access to answer the questions a sales deck used to cover, and most of those trials end without a paid contract.
The Shortlist Is Easy. The Proof Is Hard.
G2's 2026 Buyer Behavior Report, based on a June 2026 survey of 1,038 B2B software decision-makers, found that evaluation is now the longest stage of the buying journey, surpassing research for the first time. IT security review was the biggest source of delay, cited by 39% of buyers overall and 50% of enterprise buyers. And 70% said the pace of AI innovation is pushing them toward shorter contracts. Tim Sanders, Chief Innovation Officer at G2, said AI "has taken most of the friction out of finding software, but it raised new questions about cost, security, and internal trust."
The shortlist itself has become small and sticky. The TrustRadius 2026 B2B Buying Disconnect Report, drawn from 1,862 technology buyers and 444 vendors, found that 83% of buyers shortlisted three or fewer products. An HG Insights analysis of the same report adds that shortlists averaged just 2.7 products, 79% of buyers had already heard of a product before researching it, and 67% bought their first choice. Research, in other words, is mostly confirmation. The contest that remains is whether the product survives hands-on scrutiny from the people who will actually use, secure, and pay for it.
"FDE success starts with getting the engagement structure right." – Mukul Saha, Sr Director Analyst, Gartner
Bespoke Pilots Carry Their Own Risk
One response from vendors has been to throw engineers at the problem, embedding them with the customer to build a working solution during the evaluation. Gartner is skeptical. As The Register reported last week, Gartner predicts that by 2028, 70% of enterprises will abandon agentic AI built through vendor forward-deployed engineering, as costs rise and customers fail to build the internal capability to run what was built for them. Fewer than 20% of those engagements will turn recurring customer needs into features in the vendor's core product through 2028.
For revenue leaders, that is a warning about the shape of a proof of concept, not just its length. A pilot that only works while the vendor's engineers are in the building may win the evaluation and lose the renewal. Saha's prescription for these engagements, clear guidelines on governance, value delivery, ownership, knowledge transfer, and an exit strategy from day one, reads like a checklist any trial should be able to pass before it starts.
There is also a measurement problem. Most CRMs record a trial as a stage, not as an experience. When a buyer quietly lets a sandbox expire, the opportunity is marked closed-lost with a generic reason, and nobody learns whether the product failed a security review, confused a key user, or simply never got set up. With only about a third of trials headed for conversion, that blind spot now covers most of the funnel's late stage.
The CRO Playbook for the Evaluation Era
- Write success criteria before the trial starts. Agree with the buyer, in writing, what the trial must prove and who will judge it, so the evaluation ends in a decision rather than a quiet expiry.
- Staff the evaluation, not just the demo. Assign named owners for onboarding, security questions, and procurement during every trial, since security review is the single biggest delay buyers report.
- Instrument trial usage as a pipeline signal. Track who logs in, which features they test, and where activity stalls, and route those signals to the account team in real time.
- Scope pilots the buyer can run without you. Avoid bespoke builds that depend on your engineers staying on site, and plan the handover and exit from day one.
- Interview the buyers who trialed and walked. Ask lost evaluators what the trial failed to prove, because CRM loss codes will not tell you whether it was usability, security, or value.
- Make the paper as fast as the product. With buyers moving toward shorter contracts, a converted trial should go to a clean order form in hours, not weeks of manual redlines.
Buyers have made their shortlists easier to reach and their decisions harder to win. The revenue teams that pull ahead this cycle will be the ones that stop treating the trial as the end of the sales process and start running it as the most important part of it.


